Skip to main content
Fig. 3 | EJNMMI Research

Fig. 3

From: Influence on [18F]FDG uptake by cancer cells after anti-PD-1 therapy in an enforced-immune activated mouse tumor

Fig. 3

Flow-cytometry analysis of immune cell populations in tumors from the cGAMP-injected B16F10 model. Percentage of CD8+ cells (a), CD4+ cells (b), Foxp3+ cells (Treg, c), and CD45+ cells (d) in all cells in tumors on day 7 (n = 5–7). Percentage of CD8+ cells (e) and CD4+ cells (f) in CD45+ cells in tumors on day 7 (n = 5–7). Percentage of Foxp3+ cells (Treg, g) of CD4+ cells in tumors on day 7 (n = 5–7). Data of the non-treatment group and anti-PD-1-treated group were quoted from [11]. Data represent the mean ± SEM; *p < 0.05; **p < 0.01; † Adapted from [11]

Back to article page